Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome
Myeloproliferative neoplasms transformed into AML usually have a poor prognosis. We report a case of essential thrombocythemia with myelofibrosis that transformed into acute promyelocytic leukemia (APL) with both the t(15;17) translocation as well as the JAK2 V617F mutation. Clinically, this case wa...
Main Authors: | Theodore P. Braun, Julia E. Maxson, Anupriya Agarwal, Jennifer Dunlap, Stephen E. Spurgeon, Elie Traer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Leukemia Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048914200203 |
Similar Items
-
Clinical characteristics of a patient with de novo acute promyelocytic leukemia with JAK2 v617f mutation
by: Yi-zhi Jiang, et al.
Published: (2022-12-01) -
Insights into the role of JAK2-I724T variant in myeloproliferative neoplasms from a unique cohort of New Zealand patients
by: Christopher Puli'uvea, et al.
Published: (2024-12-01) -
Pronounced gut microbiota signatures in patients with JAK2V617F-positive essential thrombocythemia
by: Christina Schjellerup Eickhardt-Dalbøge, et al.
Published: (2023-10-01) -
Second Primary Malignancy after Acute Promyelocytic Leukemia: A Population-Based Study
by: Luana Lenzi, et al.
Published: (2020-12-01) -
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG
by: Smith Kungwankiattichai, et al.
Published: (2023-12-01)